Question Title

1. According to the Centers for Disease Control and Prevention 2019 list of priority pathogens, which of the following bacteria is considered an urgent threat? (Required.)

Question Title

2. According to SENTRY Program data, which of the following pathogens has shown little to no increase in prevalence between 1997-2000 and 2013-2016? (Required.)

Question Title

3. Which of the following carbapenemases is commonly found in North America and is not classified as a metallo-beta-lactamase? (Required.)

Question Title

4. Which of the following newer antimicrobials exhibits the most potent activity against MDR P. aeruginosa? (Required.)

Question Title

5. Newer beta-lactam/beta-lactamase inhibitor agents can provide activity against all of the following resistance types except: (Required.)

Question Title

6. Which of the following antimicrobials would be preferred for the treatment of urinary tract infection caused by ESBL-producing E. coli? (Required.)

Question Title

7. A 63-year-old man who has been hospitalized and intubated for 5 days following myocardial infarction develops nosocomial pneumonia. Rapid molecular diagnostics is performed on a BAL sample and indicates a KPC-producing Gram-negative organism. Which of the following would be the most appropriate antimicrobial agent? (Required.)

Question Title

8. Which of the following is not an anticipated goal of rapid diagnostic testing? (Required.)

T